# Study Comparing Desirudin With Heparin to Prevent Vein Clots After Heart and Lung Surgery

> **NCT00329433** · PHASE2,PHASE3 · COMPLETED · sponsor: **Washington University School of Medicine** · enrollment: 120 (actual)

## Conditions studied

- Deep Venous Thrombosis

## Interventions

- **DRUG:** Desirudin (Iprivask™)
- **DRUG:** Heparin

## Key facts

- **NCT ID:** NCT00329433
- **Lead sponsor:** Washington University School of Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-05
- **Primary completion:** 2008-10
- **Final completion:** 2008-10
- **Target enrollment:** 120 (ACTUAL)
- **Last updated:** 2019-03-05

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00329433

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00329433, "Study Comparing Desirudin With Heparin to Prevent Vein Clots After Heart and Lung Surgery". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT00329433. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*